May 9, 2017 / 11:48 AM / 3 months ago

BRIEF-Spark Therapeutics reports Q1 loss per share $1.70

May 9 (Reuters) - Spark Therapeutics Inc:

* Spark therapeutics reports first quarter 2017 financial results and recent business progress

* Q1 loss per share $1.70

* Q1 earnings per share view $-1.26 -- thomson reuters I/B/E/S

* Spark Therapeutics Inc - plan to provide an initial update on phase 1/2 trial for SPK-8011 in hemophilia a in July or August 2017

* Qtrly revenues $ 1.27 million versus $ 1.29 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below